Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BRLI: 31.82 (+0.55), AXGN: 3.85 (+0.17), AZPN: 36.69 (+0.28), ARQL: 1.15 (+0.01), ADUS: 23.80 (-0.19)
Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Dec 18, 3:55PM CST
BRLI: 31.82 (+0.55)
BioReference Laboratories, Inc. Announces Quarterly and Yearly Record Revenues, Net Income and Patient Volumes
GlobeNewswire - Thu Dec 18, 11:56AM CST
Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) announces record fourth quarter and full fiscal year results for revenues, net income and patient volumes. Except for per share data or where otherwise noted, numbers are in thousands.
BRLI: 31.82 (+0.55)
Bio-Reference Laboratories (BRLI) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Dec 18, 9:25AM CST
BRLI: 31.82 (+0.55)
BioReference Lab ups earnings 65% in FQ4
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 7:53AM CST
BRLI: 31.82 (+0.55)
Bio-Reference Laboratories posts 4Q profit
Automated Insights - Thu Dec 18, 7:39AM CST
ELMWOOD PARK, N.J. (AP) _ Bio-Reference Laboratories Inc. (BRLI) on Thursday reported earnings of $18.3 million, or 66 cents per share, in its fiscal fourth quarter.
BRLI: 31.82 (+0.55)
Bio-Reference Lab beats by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Dec 18, 7:33AM CST
BRLI: 31.82 (+0.55)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 4:30PM CST
WGO: 22.64 (+0.25), SCHL: 35.39 (+0.07), BRLI: 31.82 (+0.55), CAG: 36.86 (-0.07), SAFM: 84.54 (+0.26), ATU: 27.21 (+0.03), WOR: 30.41 (+0.34), NEOG: 48.21 (-0.10), ACN: 91.32 (-0.10), RAD: 7.26 (-0.09)
5 Earnings Short-Squeeze Plays: BlackBerry, Pier 1 and More
at The Street - Tue Dec 16, 11:39AM CST
You only need to find a few of these stocks in a year to juice your portfolio returns.
WGO: 22.64 (+0.25), SCHL: 35.39 (+0.07), BRLI: 31.82 (+0.55), PIR: 15.33 (-0.11), BBRY: 10.67 (-0.13)
United States Medical Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/lncwzs/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical Laboratories Industry (U.S.) to reach $218.2 billion by 2021. - Medical Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - Medytox Solutions Inc - NeoGenomics Inc - Psychemedics Corporation - Quest Diagnostics Inc For more information visit http://www.researchandmarkets.com/research/lncwzs/medical Source: Plunkett Research Ltd
PMD: 14.90 (+0.05), HH: 0.53 (unch), BRLI: 31.82 (+0.55), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)
United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.53 (unch), BRLI: 31.82 (+0.55), RDNT: 9.41 (-0.08), NEO: 4.03 (-0.10), DGX: 67.94 (-0.16), LH: 107.69 (+0.56), GHDX: 32.44 (+1.32)
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
GlobeNewswire - Thu Dec 11, 7:56AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for 2014 before the open of market trading on Thursday, December 18, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 31.82 (+0.55)
Bio-Reference Laboratories Tested: Undisclosed Lawsuit Alleges Fraud, Ex-Employees Speak Out
The GeoTeam - Seeking Alpha - Wed Dec 10, 9:15AM CST
By now, some of the extremely obvious risks to investing in Bio-Reference Laboratories (NASDAQ: BRLI ) have been in the public domain for a while. Questions have been raised about ties to organized crime, stuffing envelopes full of cash for...
BRLI: 31.82 (+0.55), DGX: 67.94 (-0.16), LH: 107.69 (+0.56)
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
Brian Hamilton - ZACKS - Mon Nov 24, 12:00AM CST
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
BRLI: 31.82 (+0.55), IVC: 16.80 (+0.20), STE: 66.76 (+0.85), MMSI: 17.17 (+0.01)
CR Bard (BCR) Scales 52-Week High on Strong Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 12:10PM CST
Impressive third-quarter 2014 results reflecting double-digit bottom-line growth, the recent FDA approval for its Lutonix DCB along with a robust product pipeline contribute to the growth trajectory of this company.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85)
DENTSPLY (XRAY) Hits New 52-Week High on Q3 Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 10:40AM CST
DENTSPLY International Inc. (XRAY) continues to execute on its overall growth strategy via margin expansion, better asset utilization and product innovation.
ABC: 91.60 (+0.18), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85), XRAY: 53.76 (-0.24)
MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:00AM CST
MWI Veterinary's (MWIV) share price has declined 8.7% since the announcement of the fourth quarter results to close at $155.00 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), MWIV: 172.76 (-0.28)
Henry Schein Tops Q3 Earnings, Revenues; Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:30AM CST
Henry Schein's (HSIC) share price jumped 6.1% to eventually close at $129.62 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), HSIC: 137.87 (+0.15)
Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 9:10AM CST
Following the earnings release, Steris' (STE) share price rose 1.9% to eventually close at $63.64 yesterday.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), BRLI: 31.82 (+0.55), STE: 66.76 (+0.85)